|
- The New England Journal of Medicine | Research Review Articles on . . .
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of
- Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection . . .
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m
- Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream . . .
Bloodstream infections are associated with substantial morbidity and mortality Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain In a multicenter, non
- Sepsis and Septic Shock | New England Journal of Medicine
Sepsis is a life-threatening, heterogeneous disorder involving a dysregulated immune response to infection Research to identify subtypes and targeted therapies for host dysregulation is ongoing
- Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common Evidence of sexual exchange of bacterial vaginosis–associated organisms between partners suggests that
- Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
Zimislecel is an allogeneic stem cell–derived islet-cell therapy Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed We conducted a phase 1–2 study of
- Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with . . .
Nemolizumab is a subcutaneously administered humanized monoclonal antibody against interleukin-31 receptor A, which is involved in pruritus and inflammation in atopic dermatitis In phase 2 studies
- Hemophagocytic Lymphohistiocytosis | New England Journal of Medicine
HLH, a cytokine-mediated hyperinflammation syndrome, causes fever, pancytopenia, and hemophagocytosis and is often fatal Antiinflammatory agents, etoposide, and interferon-γ antibody are the
|
|
|